¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"lymph node permeability factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
platelet factor 3
Ç÷¼ÒÆÇÀÎÀÚ3
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ4
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ħÀüÀÎÀÚ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibitory factor
ÇÁ·Î¶ôƾºÐºñ¾ïÁ¦ÀÎÀÚ
prolactin releasing factor
ÇÁ·Î¶ôƾºÐºñÀÎÀÚ
properdin factor B
ÇÁ·ÎÆä¸£µòBÀÎÀÚ
properdin factor D
ÇÁ·ÎÆä¸£µòDÀÎÀÚ
properdin factor E
ÇÁ·ÎÆä¸£µòEÀÎÀÚ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ
psychogenic factor
Á¤½Å¼ºÀÎÀÚ
psychological factor
½É¸®¿äÀÎ
psychosocial factor
½É¸®»çȸ¿äÀÎ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
resistancetransfer factor
³»¼ºÀü´ÞÀÎÀÚ
reticuloendothelial depressant factor
¼¼¸Á³»Çǰè¾ïÁ¦ÀÎÀÚ, ±×¹°³»Çǰè¾ïÁ¦ÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀ¯»çÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
roentgen-to-rad conversion factor
·ÛÆ®°Õ¶óµåº¯È¯°è¼ö
safety factor
¾ÈÀü°è¼ö
scatter factor
»ê¶õ°è¼ö
sebotropic factor
Áö·çÃËÁøÀÎÀÚ
somatotropin release inhibiting factor
¼ºÀåÈ£¸£¸óÀ¯¸®¾ïÁ¦ÀÎÀÚ
spreading factor
È®»êÀÎÀÚ
stable factor
¾ÈÁ¤ÀÎÀÚ
stroma factor
¹öÆÀÁúÀÎÀÚ
sunprotective factor
Àϱ¤º¸È£Áö¼ö
testis-determining factor
°íȯ°áÁ¤ÀÎÀÚ
therapeutic gain factor
Ä¡·áÀ̵æ°è¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
growth factor
¼ºÀå ÀÎÀÚ(à÷íþ ì×í)
growth factor, B cell (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
growth hormone-releasing factor
¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ<--¹æÃâÀÎÀÚ>
growth promoting factor
¼ºÀåÃËÁøÀÎÀÚ(à÷íþõµòäì×í), ¹ßÀ°ÃËÁø¹°Áú(Û¡ëÀõµòäÚªòõ)
hageman factor
ÇϰԸ¸ ÀÎÀÚ, Hageman ÀÎÀÚ
hematopoietic growth factor
Á¶Ç÷¼ºÀåÀÎÀÚ
hemorrhagic diathesis,clotting factor abnormalities
ÀÀ°íÀÎÀÚ ÀÌ»ó
hepatocyte growth factor
°£¼¼Æ÷¼ºÀåÀÎÀÚ
histamine sensitizing factor =HSF
È÷½ºÅ¸¹Î°¨ÀÛÀÎÀÚ(¡ÊïíÂì×í).
homologous restriction factor
µ¿Á¾Á¦ÇÑÀÎÀÚ
hyperglycemic glycogenolytic factor
°íÇ÷´ç¼º ´ç¿øºÐÇØ(¼º) ÀÎÀÚ.
hypothalamic releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ(ë¤×ãì×í).
hypothalamic releasing factor
½Ã»óÇϺιæÃâÀÎÀÚ.
hypothalamus releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ.
inhibition(-tory) factor, macrophage migration
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
intercellular lymph
¼¼Æ÷°£(á¬øàÊà)¸²ÇÁ.
intercostal lymph nodes
´Á°ñ»çÀ̸²ÇÁÀý, ´Á°£(×ÎÊà)¸²ÇÁÀý.
intercostal lymph nodes
°¥ºñ»çÀ̸²ÇÁÀý
interiliac lymph nodes
¾ûµ¢Ç÷°ü»çÀ̸²ÇÁÀý
intermediate lumbar lymph nodes
Áß°£Ç㸮¸²ÇÁÀý
intermediate lymph nodes
Áß°£¸²ÇÁÀý
internal iliac lymph nodes
¹æ»ç ¼ÓÀå°ñµ¿¸Æ¸²ÇÁÀý, ³»Àå°ñ(Ò® Íé)¸²ÇÁ
internal iliac lymph nodes
¼Ó¾ûµ¢¸²ÇÁÀý
internal maxillary lymph nodes
interpectoral lymph nodes
°¡½¿±Ù»çÀ̸²ÇÁÀý
intraglandular lymph nodes
»ù¼Ó¸²ÇÁÀý
intravascular lymph
¸Æ°ü³»(ØæÎ·Ò®)¸²ÇÁ.
jugular lymph sac
jugulodigastric lymph nodes
¹æ»ç ¸ñÁ¤¸ÆµÎÈû»ì±Ù¸²ÇÁÀý, °æÁ¤¸ÆÀ̺¹±Ù(
juguloomohyoid lymph nodes
¹æ»ç ¸ñÁ¤¸Æ°ß°©¼³°ñ±Ù¸²ÇÁÀý, °æÁ¤¸Æ°ß°©?
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½